Beryl Drugs Limited (BOM:524606)

Beryl Drugs Revenue

Beryl Drugs had revenue of 51.20M INR in the quarter ending September 30, 2025, a decrease of -8.80%. This brings the company's revenue in the last twelve months to 191.97M, down -14.53% year-over-year. In the fiscal year ending March 31, 2025, Beryl Drugs had annual revenue of 211.46M, down -20.89%.

• Revenue (ttm): 191.97M
• Revenue Growth: -14.53%
• P/S Ratio: 0.59
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 112.85M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2025	211.46M	-55.83M	-20.89%
Mar 31, 2024	267.30M	-1.41M	-0.53%
Mar 31, 2023	268.71M	122.67M	84.00%
Mar 31, 2022	146.04M	5.11M	3.62%
Mar 31, 2021	140.93M	12.78M	9.97%